NCT07310784 2026-03-03A Phase II Trial of LM103 in Advanced MelanomaSuzhou BlueHorse Therapeutics Co., Ltd.Phase 2 Recruiting92 enrolled
NCT03818893 2019-01-30Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PIIOsaka UniversityPhase 2 Unknown46 enrolled